当前位置：
X-MOL 学术
›
Signal Transduct. Target Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulation.
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2021-08-26 , DOI: 10.1038/s41392-021-00737-7 Chen Hua 1 , Qinhai Ma 2 , Yun Zhu 3 , Shuai Xia 1 , Zezhong Liu 1 , Lin Li 4 , Lu Lu 1 , Nanshan Zhong 2, 5 , Shuwen Liu 4 , Zifeng Yang 2, 5 , Shibo Jiang 1
中文翻译：
重新利用临床使用的抗 HPV 药物作为鼻内制剂预防和治疗 SARS-CoV-2 感染。
更新日期：2021-08-26
Signal Transduction and Targeted Therapy ( IF 40.8 ) Pub Date : 2021-08-26 , DOI: 10.1038/s41392-021-00737-7 Chen Hua 1 , Qinhai Ma 2 , Yun Zhu 3 , Shuai Xia 1 , Zezhong Liu 1 , Lin Li 4 , Lu Lu 1 , Nanshan Zhong 2, 5 , Shuwen Liu 4 , Zifeng Yang 2, 5 , Shibo Jiang 1
Affiliation
中文翻译：
重新利用临床使用的抗 HPV 药物作为鼻内制剂预防和治疗 SARS-CoV-2 感染。
京公网安备 11010802027423号